Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 1999Clinical Pharmacology & Therapeutics

Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4

View Full Paper
Ask AI
Bookmark
Share

Authors

SBS. BallUniversity of LiverpoolJSJoAnn ScatinaRutgers, The State University of New JerseyJKJohn Y. KaoUniversity of Michigan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ball et al. (1999) studied this question.

synapsesocial.com/papers/6a7e4bc5760ccf6bd0990eb7https://doi.org/10.1016/s0009-9236(99)70037-8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PREDICTION OF INTERPATIENT AND INTRAPATIENT VARIATION IN OG 37–325 DOSING REQUIREMENTS BY THE ERYTHROMYCIN BREATH TEST1994 · 16 citations
  2. 2CYP3A gene expression in human gut epithelium1994 · 368 citations
  3. 3PREDICTION OF INTERPATIENT AND INTRAPATIENT VARIATION IN OG 37–325 DOSING REQUIREMENTS BY THE ERYTHROMYCIN BREATH TEST1994 · 19 citations